Categories: Blog post

Breast cancer risk cut by 35% in new clinical trial

Trodelvy, in combination with Merck’s immunotherapy Keytruda, lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to new results…
Read More

Shane

Share
Published by
Shane

Recent Posts

Trump picks new leader of agency overseeing construction of White House ballroom, DC arch

Mark Paoletta has a long history in conservative legal circles and is a friend of…

51 minutes ago

Pay tribute to legendary Tim Curry by seeing ‘Rocky Horror’ on Broadway

The daring actor's immortal role lives on at Studio 54 on the Great White Way…

51 minutes ago

Croc-embossed bags are having a major moment: Here’s how to rock the runway trend for less

Croc and roll with the new it-bag for fall... More

51 minutes ago

California turns on USPS in war with feds over mail-in voting

Attorney General Rob Bonta and 23 other attorneys general are seeking to block new USPS…

51 minutes ago

2026 college football predictions: James Franklin, Virginia Tech will stun the ACC

The bookies believe it's Miami vs. the Field in the ACC this season... More

51 minutes ago